UnitedHealth Group Valuation
| UNH Stock | USD 470.38 8.86 1.92% |
At this time, the company appears to be undervalued. UnitedHealth Group has a current Real Value of $507.61 per share. The regular price of the company is $470.38. Our model measures the value of UnitedHealth Group from inspecting the company fundamentals such as Operating Margin of 0.08 %, return on equity of 0.15, and Shares Outstanding of 920.28 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting UnitedHealth Group's valuation include:
Price Book 4.3222 | Enterprise Value | Enterprise Value Ebitda 16.8301 | Price Sales 1.0611 | Forward PE 15.5039 |
Undervalued
Today
Please note that UnitedHealth Group's price fluctuation is very steady at this time. Calculation of the real value of UnitedHealth Group is based on 3 months time horizon. Increasing UnitedHealth Group's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since UnitedHealth Group is currently traded on the exchange, buyers and sellers on that exchange determine the market value of UnitedHealth Stock. However, UnitedHealth Group's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 470.38 | Real 507.61 | Target 636.78 | Hype 459.1 | Naive 459.38 |
The intrinsic value of UnitedHealth Group's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence UnitedHealth Group's stock price.
Estimating the potential upside or downside of UnitedHealth Group Incorporated helps investors to forecast how UnitedHealth stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of UnitedHealth Group more accurately as focusing exclusively on UnitedHealth Group's fundamentals will not take into account other important factors: When choosing an evaluation method for UnitedHealth Group, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
UnitedHealth Group Cash |
|
UnitedHealth Valuation Trend
UnitedHealth Group's real value analysis enables investors to forecast the earnings more efficiently. Using both UnitedHealth Group's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
UnitedHealth Revenue by Product
UnitedHealth Group Total Value Analysis
UnitedHealth Group Incorporated is at this time estimated to have company total value of 472.52 B with market capitalization of 424.73 B, debt of 72.36 B, and cash on hands of 27.91 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the UnitedHealth Group fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
472.52 B | 424.73 B | 72.36 B | 27.91 B |
UnitedHealth Group Investor Information
About 90.0% of the company outstanding shares are owned by institutional investors. The book value of UnitedHealth Group was at this time reported as 106.01. The company has Price/Earnings To Growth (PEG) ratio of 1.28. UnitedHealth Group recorded earning per share (EPS) of 15.53. The entity last dividend was issued on the 9th of December 2024. The firm had 2:1 split on the 31st of May 2005. Based on the analysis of UnitedHealth Group's profitability, liquidity, and operating efficiency, UnitedHealth Group Incorporated is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.064 | 0.0807 |
|
| |||||
| Total Cash From Operating Activities | 25.4 B | 24.2 B |
|
| |||||
| Operating Income | 33.9 B | 32.3 B |
|
|
UnitedHealth Group Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. UnitedHealth Group has an asset utilization ratio of 134.2 percent. This signifies that the Company is making $1.34 for each dollar of assets. An increasing asset utilization means that UnitedHealth Group Incorporated is more efficient with each dollar of assets it utilizes for everyday operations.UnitedHealth Group Ownership Allocation
UnitedHealth Group shows a total of 920.28 Million outstanding shares. The majority of UnitedHealth Group outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in UnitedHealth Group to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in UnitedHealth Group. Please pay attention to any change in the institutional holdings of UnitedHealth Group Incorporated as this could imply that something significant has changed or is about to change at the company. Please note that on February 14, 2025, Representative Michael McCaul of US Congress acquired $50k to $100k worth of UnitedHealth Group's common stock.UnitedHealth Group Profitability Analysis
The company reported the last year's revenue of 400.28 B. Total Income to common stockholders was 15.24 B with profit before taxes, overhead, and interest of 89.4 B.UnitedHealth Group Past Distributions to stockholders
About UnitedHealth Group Valuation
An absolute valuation paradigm, as applied to UnitedHealth Stock, attempts to find the value of UnitedHealth Group based on its fundamental and basic technical indicators. By analyzing UnitedHealth Group's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of UnitedHealth Group's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of UnitedHealth Group. We calculate exposure to UnitedHealth Group's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of UnitedHealth Group's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 89.4 B | 93.9 B | |
| Pretax Profit Margin | 0.05 | 0.06 | |
| Operating Profit Margin | 0.08 | 0.06 | |
| Net Profit Margin | 0.04 | 0.04 | |
| Gross Profit Margin | 0.22 | 0.29 |
A single share of UnitedHealth Group represents a small ownership stake in the entity. As a stockholder of UnitedHealth, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
UnitedHealth Group Dividends Analysis For Valuation
As of now, UnitedHealth Group's Dividend Yield is increasing as compared to previous years. The UnitedHealth Group's current Dividend Payout Ratio is estimated to increase to 0.55, while Dividends Paid is forecasted to increase to (7.2 B). . As of now, UnitedHealth Group's Retained Earnings are increasing as compared to previous years. The UnitedHealth Group's current Price Earnings Ratio is estimated to increase to 34.25, while Retained Earnings Total Equity is projected to decrease to under 51.1 B.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -7.5 B | -7.2 B | |
| Dividend Yield | 0.02 | 0.02 | |
| Dividend Payout Ratio | 0.52 | 0.55 | |
| Dividend Paid And Capex Coverage Ratio | 2.19 | 2.08 |
There are various types of dividends UnitedHealth Group can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of UnitedHealth shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from UnitedHealth Group Incorporated directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When UnitedHealth pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of UnitedHealth Group by the value of the dividends paid out.
UnitedHealth Group Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 929 M | |
| Quarterly Earnings Growth Y O Y | 0.026 | |
| Forward Price Earnings | 15.5039 |
UnitedHealth Group Current Valuation Indicators
Valuation refers to the process of determining the present value of UnitedHealth Group Incorporated and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value UnitedHealth we look at many different elements of the entity such as UnitedHealth's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as UnitedHealth Group, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use UnitedHealth Group's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes UnitedHealth Group's worth.Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |